Tag: respiratory endotherapy devices market report

  • Respiratory Endotherapy Devices Market Forecast To Reach $4.66 Billion By 2030: Key Growth Drivers And Industry Trends

    Respiratory Endotherapy Devices Market Forecast To Reach $4.66 Billion By 2030: Key Growth Drivers And Industry Trends

    Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

    Respiratory Endotherapy Devices Market Value Growth And Long-Term Outlook

    The market for respiratory endotherapy devices has shown substantial growth over recent years. Looking ahead, its valuation is set to climb from $3.32 billion in 2025 to $3.54 billion in 2026, maintaining a compound annual growth rate (CAGR) of 6.9%. The historical expansion can be traced to various factors including a rise in chronic respiratory diseases, an increase in lung cancer diagnosis, the expansion of interventional pulmonology, growth in hospital endoscopy units, and the demand for minimally invasive procedures.

    The respiratory endotherapy devices market is projected for substantial growth over the next few years. It is anticipated to expand to $4.66 billion by 2030, driven by a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period can be attributed to an increase in early lung screening programs, robotic bronchoscopy adoption, outpatient pulmonary procedures growth, advanced imaging integration, and precision airway therapy demand. Significant trends expected in the forecast period include minimally invasive airway intervention devices, disposable bronchoscope adoption, image guided bronchoscopic procedures, advanced endobronchial ablation systems, and smart navigation bronchoscopy tools.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=20003569&type=smp&name=Respiratory%20Endotherapy%20Devices%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Respiratory Endotherapy Devices Market Growth Factors Behind Sustained Expansion

    The increasing use of robotic-assisted bronchoscopy is projected to fuel the expansion of the respiratory endotherapy devices market moving forward. These advanced robotic-assisted bronchoscopy systems allow for precise navigation within the respiratory tract, leading to improved diagnostic accuracy and better therapeutic results. Demand for these systems is surging as healthcare providers seek less invasive options that reduce procedure time, bolster patient safety, and enhance clinical efficiency. Respiratory endotherapy devices, when assisted by robotics, facilitate complex interventions by offering real-time imaging, superior maneuverability, and greater control. For instance, in September 2025, the European Respiratory Society International Congress, a Switzerland-based membership organization, noted that the utilization of robotic-assisted bronchoscopy with integrated cone beam CT for peripheral lung lesions soared to 84.6% in 2025, a substantial rise from only 23.1% with conventional bronchoscopy in 2024. Hence, the increasing embrace of robotic-assisted bronchoscopy is propelling the growth of the respiratory endotherapy devices market.

    Respiratory Endotherapy Devices Market Segment Landscape: Which Areas Lead Development?

    The respiratory endotherapy devices market covered in this report is segmented –

    1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Systems; Biopsy Forceps; Guidewires; Catheters; Airway Stents; Endobronchial Valves; Ablation Devices; Other Endotherapy Accessories

    2) By Diagnostic Devices: Trans Bronchial Aspiration; Biopsy Forceps; Cytology Brushes; Other Diagnostic Devices

    3) By Patient Type: Adult Patients; Pediatric Patients

    4) By Specialist: Hospitals; Diagnostic Centers; Ambulatory Surgical Centers

    5) By End User: Peripheral Vascular Intervention; Endovascular Interventions; Cardiac; Interventional Radiology; Venous; Other End Users

    Subsegments:

    1) By Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Video Bronchoscopes; Disposable Bronchoscopes; Therapeutic Bronchoscopes

    2) By Endobronchial Ultrasound Systems: Radial Endobronchial Ultrasound Systems; Linear Endobronchial Ultrasound Systems; Portable Endobronchial Ultrasound Systems; Cart Based Endobronchial Ultrasound Systems; High Resolution Endobronchial Ultrasound Systems

    3) By Biopsy Forceps: Flexible Biopsy Forceps; Rigid Biopsy Forceps; Disposable Biopsy Forceps; Alligator Jaw Biopsy Forceps; Cup Biopsy Forceps

    4) By Guidewires: Hydrophilic Guidewires; Non Coated Guidewires; Steerable Guidewires; Flexible Tip Guidewires; High Strength Guidewires

    5) By Catheters: Balloon Catheters; Aspiration Catheters; Delivery Catheters; Diagnostic Catheters; Therapeutic Catheters

    6) By Airway Stents: Silicone Airway Stents; Metallic Airway Stents; Covered Airway Stents; Uncovered Airway Stents; Expandable Airway Stents

    7) By Endobronchial Valves: One Way Endobronchial Valves; Permanent Endobronchial Valves; Temporary Endobronchial Valves; Adjustable Endobronchial Valves; Implantable Endobronchial Valves

    8) By Ablation Devices: Radiofrequency Ablation Devices; Cryoablation Devices; Laser Ablation Devices; Thermal Ablation Devices; Microwave Ablation Devices

    9) By Other Endotherapy Accessories: Suction Tubes; Specimen Collection Traps; Bronchoscopy Brushes; Biopsy Needles; Airway Dilators

    Respiratory Endotherapy Devices Market Industry Trends Fueling Future Revenue Growth

    Leading firms in the respiratory endotherapy devices market are concentrating on creating innovative solutions, like endobronchial valves, with the aim of reducing treatment risks and achieving specific lung volume reduction without irreversible tissue removal. An endobronchial valve represents a minimally invasive implant, inserted via bronchoscopy into chosen airways to impede airflow to affected lung regions, thereby enabling healthier parts to operate more efficiently. For example, Olympus Canada Inc., a medical technology company based in Canada, introduced the Spiration Valve System in February 2024, designed for managing severe emphysema. This umbrella-shaped device is intended for placement in the most severely diseased lung areas through a minimally invasive bronchoscopic procedure. Its unique mechanism redirects airflow away from hyperinflated lung areas towards healthier tissue, which aids in enhancing respiratory mechanics. Being the sole endobronchial valve therapy presently accessible in Canada, it fulfills an unaddressed requirement in the treatment of severe emphysema. Clinical data from the EMPROVE trial illustrates lasting advantages over 24 months, encompassing significant enhancements in lung function, reduced breathlessness, and an improved quality of life for patients.

    Respiratory Endotherapy Devices Market Industry Leaders And Competitive Landscape

    Major companies operating in the respiratory endotherapy devices market are Johnson & Johnson, Medtronic plc, Siemens Healthineers, Stryker Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Intuitive Surgical Inc., Olympus Corporation, Hoya Corporation, Steris Healthcare, Teleflex Incorporated, Karl Storz SE & Co. KG, CookMedical, Merit Medical Systems Inc., Ambu A/S, Vygon, Richard Wolf GmbH, Vapotherm Inc, Scholly Fiberoptic GmbH, Clarus Medical LLC, ENDO-FLEX GmbH, The Lung Docs Inc., and Broncus Medical Inc.

    View The Full Respiratory Endotherapy Devices Market Report:

    https://thebusinessresearchcompany.com/report/respiratory-endotherapy-devices-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Respiratory Endotherapy Devices Market Regional Analysis And Top Geography

    North America was the largest region in the respiratory endotherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory endotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Respiratory Endotherapy Devices  Market Trends And Growth Drivers Point To Strong Future Potential

    Respiratory Endotherapy Devices Market Trends And Growth Drivers Point To Strong Future Potential

    Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

    Respiratory Endotherapy Devices Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

    The respiratory endotherapy devices market has experienced significant expansion in recent years. This market is projected to increase from $3.32 billion in 2025 to $3.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. Historically, this growth has been fueled by factors such as an escalation in chronic respiratory diseases, a rise in lung cancer diagnosis, the broadening of interventional pulmonology, the expansion of hospital endoscopy units, and the demand for minimally invasive procedures.

    The market for respiratory endotherapy devices is anticipated to experience substantial expansion in the coming years. This market is projected to reach a valuation of $4.66 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the forecast period include the rise in early lung screening programs, the adoption of robotic bronchoscopy, an increase in outpatient pulmonary procedures, the integration of advanced imaging, and the demand for precision airway therapy. Key trends expected over the forecast horizon involve minimally invasive airway intervention devices, the increasing use of disposable bronchoscopes, image-guided bronchoscopic procedures, sophisticated endobronchial ablation systems, and smart navigation bronchoscopy tools.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=33296&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

    Respiratory Endotherapy Devices Market Industry Drivers: What Is Driving Revenue Growth?

    The respiratory endotherapy devices market is anticipated to be driven by the growing integration of robotic-assisted bronchoscopy going forward. These advanced robotic-assisted bronchoscopy systems facilitate precise navigation within the respiratory tract, thereby improving diagnostic accuracy and therapeutic outcomes. The increasing demand for these systems arises as healthcare providers seek minimally invasive solutions that can reduce procedure time, enhance patient safety, and improve overall clinical efficiency. Respiratory endotherapy devices equipped with robotic assistance support complex interventions by providing real-time imaging, superior maneuverability, and enhanced control. As an example, in September 2025 , data from the European Respiratory Society International Congress , a Switzerland -based membership organization, showed that the utilization of robotic-assisted bronchoscopy with integrated cone beam CT for peripheral lung lesions increased to 84.6% in 2025 , a significant leap from just 23.1% with conventional bronchoscopy in 2024 . Consequently, the rising adoption of robotic-assisted bronchoscopy is propelling the growth of the respiratory endotherapy devices market .

    Respiratory Endotherapy Devices Market Segment Outlook: Which Categories Are Expanding The Fastest?

    The respiratory endotherapy devices market covered in this report is segmented –

    1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Systems; Biopsy Forceps; Guidewires; Catheters; Airway Stents; Endobronchial Valves; Ablation Devices; Other Endotherapy Accessories

    2) By Diagnostic Devices: Trans Bronchial Aspiration; Biopsy Forceps; Cytology Brushes; Other Diagnostic Devices

    3) By Patient Type: Adult Patients; Pediatric Patients

    4) By Specialist: Hospitals; Diagnostic Centers; Ambulatory Surgical Centers

    5) By End User: Peripheral Vascular Intervention; Endovascular Interventions; Cardiac; Interventional Radiology; Venous; Other End Users

    Subsegments:

    1) By Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Video Bronchoscopes; Disposable Bronchoscopes; Therapeutic Bronchoscopes

    2) By Endobronchial Ultrasound Systems: Radial Endobronchial Ultrasound Systems; Linear Endobronchial Ultrasound Systems; Portable Endobronchial Ultrasound Systems; Cart Based Endobronchial Ultrasound Systems; High Resolution Endobronchial Ultrasound Systems

    3) By Biopsy Forceps: Flexible Biopsy Forceps; Rigid Biopsy Forceps; Disposable Biopsy Forceps; Alligator Jaw Biopsy Forceps; Cup Biopsy Forceps

    4) By Guidewires: Hydrophilic Guidewires; Non Coated Guidewires; Steerable Guidewires; Flexible Tip Guidewires; High Strength Guidewires

    5) By Catheters: Balloon Catheters; Aspiration Catheters; Delivery Catheters; Diagnostic Catheters; Therapeutic Catheters

    6) By Airway Stents: Silicone Airway Stents; Metallic Airway Stents; Covered Airway Stents; Uncovered Airway Stents; Expandable Airway Stents

    7) By Endobronchial Valves: One Way Endobronchial Valves; Permanent Endobronchial Valves; Temporary Endobronchial Valves; Adjustable Endobronchial Valves; Implantable Endobronchial Valves

    8) By Ablation Devices: Radiofrequency Ablation Devices; Cryoablation Devices; Laser Ablation Devices; Thermal Ablation Devices; Microwave Ablation Devices

    9) By Other Endotherapy Accessories: Suction Tubes; Specimen Collection Traps; Bronchoscopy Brushes; Biopsy Needles; Airway Dilators

    #Respiratory Endotherapy Devices Market Growth Trends: What Is Influencing The Future Outlook?

    Leading firms in the respiratory endotherapy devices market are concentrating on creating sophisticated solutions, like endobronchial valves, to lessen treatment risks and accomplish precise lung volume reduction without permanent tissue removal. An endobronchial valve is a minimally invasive implant inserted through bronchoscopy into specific airways to obstruct airflow to affected lung areas, thereby enabling healthier parts to operate more efficiently. For example, in February 2024, Olympus Canada Inc., a medical technology company based in Canada, introduced the Spiration Valve System aimed at treating severe emphysema. This device, shaped like an umbrella, is intended for placement in the most severely afflicted lung regions via a minimally invasive bronchoscopic procedure. It uniquely reroutes airflow from hyperinflated lung zones towards healthier tissue, thereby enhancing respiratory mechanics. Being the sole endobronchial valve therapy presently offered in Canada, it fulfills an unaddressed requirement in managing severe emphysema. Clinical data from the EMPROVE trial indicates sustained advantages over 24 months, encompassing significant enhancements in lung function, reduced breathlessness, and improved patient quality of life.

    Respiratory Endotherapy Devices Market Key Companies And Competitive Benchmarking

    Major companies operating in the respiratory endotherapy devices market are Johnson & Johnson, Medtronic plc, Siemens Healthineers, Stryker Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Intuitive Surgical Inc., Olympus Corporation, Hoya Corporation, Steris Healthcare, Teleflex Incorporated, Karl Storz SE & Co. KG, CookMedical, Merit Medical Systems Inc., Ambu A/S, Vygon, Richard Wolf GmbH, Vapotherm Inc, Scholly Fiberoptic GmbH, Clarus Medical LLC, ENDO-FLEX GmbH, The Lung Docs Inc., and Broncus Medical Inc.

    Access The Complete Respiratory Endotherapy Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/respiratory-endotherapy-devices-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Jul_PR

    Respiratory Endotherapy Devices Market Regional Distribution: Which Areas Drive Market Expansion?

    North America was the largest region in the respiratory endotherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory endotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Respiratory Endotherapy Devices Market Expected to Reach $4.66 Billion by 2030

    Respiratory Endotherapy Devices Market Expected to Reach $4.66 Billion by 2030

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    How Is The Market Value Of The Respiratory Endotherapy Devices Market Projected To Expand During 2026–2030?

    The market for respiratory endotherapy devices has experienced significant expansion in recent years. It is anticipated to grow from $3.32 billion in 2025 to $3.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. This historical growth can be attributed to several factors, including the increasing prevalence of chronic respiratory diseases, a rise in lung cancer diagnosis, the expansion of interventional pulmonology, the growth of hospital endoscopy units, and the increasing demand for minimally invasive procedures.

    The market for respiratory endotherapy devices is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $4.66 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. Factors driving this projected growth include a rise in early lung screening programs, the adoption of robotic bronchoscopy, an expansion in outpatient pulmonary procedures, the integration of advanced imaging, and increasing demand for precision airway therapy. Key developments expected during this period involve minimally invasive airway intervention devices, the increasing use of disposable bronchoscopes, image-guided bronchoscopic procedures, sophisticated endobronchial ablation systems, and intelligent navigation bronchoscopy tools.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=33296&type=smp

    Which Drivers Are Advancing The Respiratory Endotherapy Devices Market Growth?

    The expanding integration of robotic-assisted bronchoscopy is projected to boost the respiratory endotherapy devices market moving forward. These sophisticated robotic systems represent cutting-edge solutions, facilitating accurate navigation within the respiratory tract, which in turn elevates diagnostic precision and therapeutic results. The uptake of these systems is surging because medical professionals are increasingly looking for minimally invasive approaches that shorten procedure durations, heighten patient safety, and optimize clinical workflows. Respiratory endotherapy instruments, when augmented with robotic assistance, facilitate intricate medical procedures by offering real-time visualization, superior handling capabilities, and improved command. For example, data from September 2025, reported by the European Respiratory Society International Congress, a Switzerland-based membership organization, indicated that the application of robotic-assisted bronchoscopy coupled with integrated cone beam CT for peripheral lung lesions saw an increase to 84.6% in 2025, significantly higher than the mere 23.1% observed with conventional bronchoscopy in 2024. Consequently, the growing acceptance of robotic-assisted bronchoscopy is fueling the expansion of the respiratory endotherapy devices market.

    Which Segment Groups Define The Respiratory Endotherapy Devices Market Landscape?

    The respiratory endotherapy devices market covered in this report is segmented –

    1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Systems; Biopsy Forceps; Guidewires; Catheters; Airway Stents; Endobronchial Valves; Ablation Devices; Other Endotherapy Accessories

    2) By Diagnostic Devices: Trans Bronchial Aspiration; Biopsy Forceps; Cytology Brushes; Other Diagnostic Devices

    3) By Patient Type: Adult Patients; Pediatric Patients

    4) By Specialist: Hospitals; Diagnostic Centers; Ambulatory Surgical Centers

    5) By End User: Peripheral Vascular Intervention; Endovascular Interventions; Cardiac; Interventional Radiology; Venous; Other End Users

    Subsegments:

    1) By Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Video Bronchoscopes; Disposable Bronchoscopes; Therapeutic Bronchoscopes

    2) By Endobronchial Ultrasound Systems: Radial Endobronchial Ultrasound Systems; Linear Endobronchial Ultrasound Systems; Portable Endobronchial Ultrasound Systems; Cart Based Endobronchial Ultrasound Systems; High Resolution Endobronchial Ultrasound Systems

    3) By Biopsy Forceps: Flexible Biopsy Forceps; Rigid Biopsy Forceps; Disposable Biopsy Forceps; Alligator Jaw Biopsy Forceps; Cup Biopsy Forceps

    4) By Guidewires: Hydrophilic Guidewires; Non Coated Guidewires; Steerable Guidewires; Flexible Tip Guidewires; High Strength Guidewires

    5) By Catheters: Balloon Catheters; Aspiration Catheters; Delivery Catheters; Diagnostic Catheters; Therapeutic Catheters

    6) By Airway Stents: Silicone Airway Stents; Metallic Airway Stents; Covered Airway Stents; Uncovered Airway Stents; Expandable Airway Stents

    7) By Endobronchial Valves: One Way Endobronchial Valves; Permanent Endobronchial Valves; Temporary Endobronchial Valves; Adjustable Endobronchial Valves; Implantable Endobronchial Valves

    8) By Ablation Devices: Radiofrequency Ablation Devices; Cryoablation Devices; Laser Ablation Devices; Thermal Ablation Devices; Microwave Ablation Devices

    9) By Other Endotherapy Accessories: Suction Tubes; Specimen Collection Traps; Bronchoscopy Brushes; Biopsy Needles; Airway Dilators

    What Trends Are Driving Changes In The Respiratory Endotherapy Devices Market?

    Leading companies in the respiratory endotherapy devices market are concentrating on creating sophisticated solutions, such as endobronchial valves, with the aim of reducing treatment risks while achieving precise lung volume reduction without irreversible tissue removal. An endobronchial valve is a minimally invasive implant placed via bronchoscopy into selected airways to impede airflow to diseased lung areas, thereby enabling healthier regions to operate more efficiently. For instance, in February 2024, Olympus Canada Inc., a Canada-based medical technology company, launched the Spiration Valve System for the treatment of severe emphysema. This umbrella-shaped device is designed for minimally invasive bronchoscopic placement in the most affected lung regions. It uniquely diverts airflow away from hyperinflated lung areas toward healthier tissue, supporting improved respiratory mechanics. Being the sole endobronchial valve therapy presently accessible in Canada, it fulfills a critical unmet need in managing severe emphysema. Clinical data from the EMPROVE trial illustrates sustained advantages over 24 months, encompassing significant enhancements in lung function, reduced breathlessness, and an improved quality of life for patients.

    Which Key Players Are Active In The Respiratory Endotherapy Devices Market?

    Major companies operating in the respiratory endotherapy devices market are Johnson & Johnson, Medtronic plc, Siemens Healthineers, Stryker Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Intuitive Surgical Inc., Olympus Corporation, Hoya Corporation, Steris Healthcare, Teleflex Incorporated, Karl Storz SE & Co. KG, CookMedical, Merit Medical Systems Inc., Ambu A/S, Vygon, Richard Wolf GmbH, Vapotherm Inc, Scholly Fiberoptic GmbH, Clarus Medical LLC, ENDO-FLEX GmbH, The Lung Docs Inc., and Broncus Medical Inc.

    Access The Complete Respiratory Endotherapy Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/respiratory-endotherapy-devices-market-report

    Which Region Commands The Largest Share Of The Respiratory Endotherapy Devices Market?

    North America was the largest region in the respiratory endotherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory endotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access a Customized Respiratory Endotherapy Devices Market Report for Deeper Competitive Insights

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Respiratory Endotherapy Devices Market Expected To Grow Steadily And Approach $4.66 Billion By 2030

    Respiratory Endotherapy Devices Market Expected To Grow Steadily And Approach $4.66 Billion By 2030

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Forecasted Market Size Trajectory Of The Respiratory Endotherapy Devices Market From 2026 To 2030?

    The respiratory endotherapy devices market has demonstrated robust expansion over recent years. It is anticipated to expand from $3.32 billion in 2025 to $3.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. The primary drivers for its historical growth include a rise in chronic respiratory diseases, growth in lung cancer diagnosis, expansion of interventional pulmonology, hospital endoscopy unit growth, and the increasing demand for minimally invasive procedures.

    The respiratory endotherapy devices market size is anticipated to undergo significant expansion in the upcoming years, with projections indicating a rise to $4.66 billion by 2030, achieving this with a compound annual growth rate (CAGR) of 7.1%. This projected growth throughout the forecast period is primarily driven by an increase in early lung screening initiatives, the widespread adoption of robotic bronchoscopy, a surge in outpatient pulmonary procedures, the integration of advanced imaging technologies, and the escalating demand for precision airway therapy. Prominent trends expected during this period include the development of minimally invasive airway intervention devices, the increasing uptake of disposable bronchoscopes, advancements in image-guided bronchoscopic procedures, the emergence of sophisticated endobronchial ablation systems, and the introduction of smart navigation tools for bronchoscopy.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=33296&type=smp

    Which Factors Are Influencing The Growth Of The Respiratory Endotherapy Devices Market?

    The increasing integration of robotic-assisted bronchoscopy is anticipated to boost the expansion of the respiratory endotherapy devices market in the future. These advanced robotic-assisted bronchoscopy systems allow for highly accurate navigation inside the respiratory tract, leading to better diagnostic precision and improved patient treatment results. There is a growing need for these systems as healthcare professionals increasingly look for less invasive options that can shorten procedure duration, heighten patient safety, and optimize clinical operations. When fitted with robotic assistance, respiratory endotherapy devices facilitate intricate interventions through capabilities like real-time imaging, superior maneuverability, and augmented control. As an illustration, the European Respiratory Society International Congress, a Switzerland-based membership organization, reported in September 2025 that the application of robotic-assisted bronchoscopy featuring integrated cone beam CT for addressing peripheral lung lesions escalated to 84.6% in 2025, a significant increase from merely 23.1% when using conventional bronchoscopy in 2024. Consequently, the growing acceptance of robotic-assisted bronchoscopy is a key factor propelling the expansion of the respiratory endotherapy devices market.

    Which Segment Types Are Examined In The Respiratory Endotherapy Devices Market Segment Study?

    The respiratory endotherapy devices market covered in this report is segmented –

    1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Systems; Biopsy Forceps; Guidewires; Catheters; Airway Stents; Endobronchial Valves; Ablation Devices; Other Endotherapy Accessories

    2) By Diagnostic Devices: Trans Bronchial Aspiration; Biopsy Forceps; Cytology Brushes; Other Diagnostic Devices

    3) By Patient Type: Adult Patients; Pediatric Patients

    4) By Specialist: Hospitals; Diagnostic Centers; Ambulatory Surgical Centers

    5) By End User: Peripheral Vascular Intervention; Endovascular Interventions; Cardiac; Interventional Radiology; Venous; Other End Users

    Subsegments:

    1) By Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Video Bronchoscopes; Disposable Bronchoscopes; Therapeutic Bronchoscopes

    2) By Endobronchial Ultrasound Systems: Radial Endobronchial Ultrasound Systems; Linear Endobronchial Ultrasound Systems; Portable Endobronchial Ultrasound Systems; Cart Based Endobronchial Ultrasound Systems; High Resolution Endobronchial Ultrasound Systems

    3) By Biopsy Forceps: Flexible Biopsy Forceps; Rigid Biopsy Forceps; Disposable Biopsy Forceps; Alligator Jaw Biopsy Forceps; Cup Biopsy Forceps

    4) By Guidewires: Hydrophilic Guidewires; Non Coated Guidewires; Steerable Guidewires; Flexible Tip Guidewires; High Strength Guidewires

    5) By Catheters: Balloon Catheters; Aspiration Catheters; Delivery Catheters; Diagnostic Catheters; Therapeutic Catheters

    6) By Airway Stents: Silicone Airway Stents; Metallic Airway Stents; Covered Airway Stents; Uncovered Airway Stents; Expandable Airway Stents

    7) By Endobronchial Valves: One Way Endobronchial Valves; Permanent Endobronchial Valves; Temporary Endobronchial Valves; Adjustable Endobronchial Valves; Implantable Endobronchial Valves

    8) By Ablation Devices: Radiofrequency Ablation Devices; Cryoablation Devices; Laser Ablation Devices; Thermal Ablation Devices; Microwave Ablation Devices

    9) By Other Endotherapy Accessories: Suction Tubes; Specimen Collection Traps; Bronchoscopy Brushes; Biopsy Needles; Airway Dilators

    Which Trends Are Influencing Demand In The Respiratory Endotherapy Devices Market?

    Leading companies active in the respiratory endotherapy devices market are concentrating on developing advanced solutions, such as endobronchial valves, to minimize risks associated with treatment while achieving precise lung volume reduction without permanent tissue removal. An endobronchial valve is a minimally invasive implant introduced via bronchoscopy into selected airways to block airflow to diseased lung regions, enabling healthier areas to function more effectively. For instance, in February 2024, Olympus Canada Inc., a Canada-based medical technology company, launched the Spiration Valve System for managing severe emphysema. This umbrella-shaped device is designed for placement in the most severely diseased lung regions using a minimally invasive bronchoscopic procedure. It uniquely redirects airflow away from hyperinflated lung areas towards healthier tissue, thereby supporting improved respiratory mechanics. As the sole endobronchial valve therapy currently available in Canada, it addresses an unmet need in severe emphysema management. Clinical evidence from the EMPROVE trial demonstrates sustained benefits through 24 months, including significant improvements in lung function, reductions in breathlessness, and enhanced patient quality of life.

    Which Players Are Part Of The Competitive Landscape Of The Respiratory Endotherapy Devices Market?

    Major companies operating in the respiratory endotherapy devices market are Johnson & Johnson, Medtronic plc, Siemens Healthineers, Stryker Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Intuitive Surgical Inc., Olympus Corporation, Hoya Corporation, Steris Healthcare, Teleflex Incorporated, Karl Storz SE & Co. KG, CookMedical, Merit Medical Systems Inc., Ambu A/S, Vygon, Richard Wolf GmbH, Vapotherm Inc, Scholly Fiberoptic GmbH, Clarus Medical LLC, ENDO-FLEX GmbH, The Lung Docs Inc., and Broncus Medical Inc.

    Get The Full Respiratory Endotherapy Devices Market Report:

    https://www.thebusinessresearchcompany.com/report/respiratory-endotherapy-devices-market-report

    Which Region Leads The Respiratory Endotherapy Devices Market In Terms Of Market Share?

    North America was the largest region in the respiratory endotherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory endotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Respiratory Endotherapy Devices Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=33296&type=smp

    Browse Through More Reports Similar to the Global Respiratory Endotherapy Devices Market 2026, By The Business Research Company

    Respiratory Devices And Equipment Therapeutic Market Report 2026

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

    Endotherapy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/endotherapy-devices-global-market-report

    Respiratory Devices And Equipment Therapeutic And Diagnostic Market Report 2026

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Respiratory Endotherapy Devices Market Expected to Reach $4.66 Billion by 2030

    Respiratory Endotherapy Devices Market Expected to Reach $4.66 Billion by 2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Will The Market Size Of The Respiratory Endotherapy Devices Market Evolve From 2026 To 2030?

    The respiratory endotherapy devices market size has experienced significant expansion in recent years. It is anticipated to increase from $3.32 billion in 2025 to $3.54 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. Historically, this growth has been fueled by factors such as a rise in chronic respiratory diseases, improved lung cancer diagnosis, the expansion of interventional pulmonology, growth in hospital endoscopy units, and an elevated demand for minimally invasive procedures.

    The market size for respiratory endotherapy devices is projected to experience robust growth in the upcoming years. It is anticipated to expand to $4.66 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is attributable to several factors, including an increase in early lung screening programs, the adoption of robotic bronchoscopy, a rise in outpatient pulmonary procedures, the integration of advanced imaging, and a growing demand for precision airway therapy. Prominent trends expected in this period involve minimally invasive airway intervention devices, the increasing use of disposable bronchoscopes, image guided bronchoscopic procedures, sophisticated endobronchial ablation systems, and intelligent navigation bronchoscopy tools.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=33296&type=smp

    Which Major Factors Are Driving The Expansion Of The Respiratory Endotherapy Devices Market?

    The increasing integration of robotic-assisted bronchoscopy is anticipated to boost the expansion of the respiratory endotherapy devices market in the future. These systems represent sophisticated technologies facilitating accurate navigation within the airways, thereby enhancing diagnostic precision and treatment results. Growing demand for these systems stems from healthcare professionals’ pursuit of less invasive options that cut down procedure durations, bolster patient safety, and optimize clinical workflows. Respiratory endotherapy devices incorporating robotic aid assist in intricate procedures through the provision of real-time imaging, improved handling, and superior control. For example, data from September 2025 by the European Respiratory Society International Congress, a Switzerland-based membership organization, indicates that the adoption of robotic-assisted bronchoscopy combined with integrated cone beam CT for peripheral lung lesions reached 84.6% in 2025, a significant increase from only 23.1% using conventional bronchoscopy in 2024. Consequently, the expanding use of robotic-assisted bronchoscopy is fueling the expansion of the respiratory endotherapy devices market.

    Which Segment Areas Are Covered In The Respiratory Endotherapy Devices Market Analysis?

    The respiratory endotherapy devices market covered in this report is segmented –

    1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Systems; Biopsy Forceps; Guidewires; Catheters; Airway Stents; Endobronchial Valves; Ablation Devices; Other Endotherapy Accessories

    2) By Diagnostic Devices: Trans Bronchial Aspiration; Biopsy Forceps; Cytology Brushes; Other Diagnostic Devices

    3) By Patient Type: Adult Patients; Pediatric Patients

    4) By Specialist: Hospitals; Diagnostic Centers; Ambulatory Surgical Centers

    5) By End User: Peripheral Vascular Intervention; Endovascular Interventions; Cardiac; Interventional Radiology; Venous; Other End Users

    Subsegments:

    1) By Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Video Bronchoscopes; Disposable Bronchoscopes; Therapeutic Bronchoscopes

    2) By Endobronchial Ultrasound Systems: Radial Endobronchial Ultrasound Systems; Linear Endobronchial Ultrasound Systems; Portable Endobronchial Ultrasound Systems; Cart Based Endobronchial Ultrasound Systems; High Resolution Endobronchial Ultrasound Systems

    3) By Biopsy Forceps: Flexible Biopsy Forceps; Rigid Biopsy Forceps; Disposable Biopsy Forceps; Alligator Jaw Biopsy Forceps; Cup Biopsy Forceps

    4) By Guidewires: Hydrophilic Guidewires; Non Coated Guidewires; Steerable Guidewires; Flexible Tip Guidewires; High Strength Guidewires

    5) By Catheters: Balloon Catheters; Aspiration Catheters; Delivery Catheters; Diagnostic Catheters; Therapeutic Catheters

    6) By Airway Stents: Silicone Airway Stents; Metallic Airway Stents; Covered Airway Stents; Uncovered Airway Stents; Expandable Airway Stents

    7) By Endobronchial Valves: One Way Endobronchial Valves; Permanent Endobronchial Valves; Temporary Endobronchial Valves; Adjustable Endobronchial Valves; Implantable Endobronchial Valves

    8) By Ablation Devices: Radiofrequency Ablation Devices; Cryoablation Devices; Laser Ablation Devices; Thermal Ablation Devices; Microwave Ablation Devices

    9) By Other Endotherapy Accessories: Suction Tubes; Specimen Collection Traps; Bronchoscopy Brushes; Biopsy Needles; Airway Dilators

    What Key Developments And Trends Are Impacting The Respiratory Endotherapy Devices Market?

    Leading companies in the respiratory endotherapy devices market are concentrating on developing advanced solutions, such as endobronchial valves, to minimize treatment risks while achieving targeted lung volume reduction without permanent tissue removal. An endobronchial valve is a minimally invasive implant inserted via bronchoscopy into selected airways to block airflow to diseased lung regions, enabling healthier areas to function more effectively. For example, in February 2024, Olympus Canada Inc., a medical technology firm based in Canada, launched the Spiration Valve System for the treatment of severe emphysema. This umbrella-shaped device is designed to be placed in the most severely diseased lung regions using a minimally invasive bronchoscopic procedure. It uniquely redirects airflow away from hyperinflated lung areas toward healthier tissue, supporting improved respiratory mechanics. As the only endobronchial valve therapy currently accessible in Canada, it addresses an unmet need in the management of severe emphysema. Clinical evidence from the EMPROVE trial demonstrates sustained benefits over 24 months, including significant improvements in lung function, breathlessness, and patient quality of life.

    Which Leading Firms Are Contributing To The Growth Of The Respiratory Endotherapy Devices Market?

    Major companies operating in the respiratory endotherapy devices market are Johnson & Johnson, Medtronic plc, Siemens Healthineers, Stryker Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Intuitive Surgical Inc., Olympus Corporation, Hoya Corporation, Steris Healthcare, Teleflex Incorporated, Karl Storz SE & Co. KG, CookMedical, Merit Medical Systems Inc., Ambu A/S, Vygon, Richard Wolf GmbH, Vapotherm Inc, Scholly Fiberoptic GmbH, Clarus Medical LLC, ENDO-FLEX GmbH, The Lung Docs Inc., and Broncus Medical Inc.

    Read the full respiratory endotherapy devices market report here:

    https://www.thebusinessresearchcompany.com/report/respiratory-endotherapy-devices-market-report

    Which Regions Are Poised For Strategic Growth In The Respiratory Endotherapy Devices Market?

    North America was the largest region in the respiratory endotherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory endotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Respiratory Endotherapy Devices Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=33296&type=smp

    Browse Through More Reports Similar to the Global Respiratory Endotherapy Devices Market 2026, By The Business Research Company

    Respiratory Devices And Equipment Therapeutic Market Report 2026

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

    Endotherapy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/endotherapy-devices-global-market-report

    Respiratory Devices And Equipment Therapeutic And Diagnostic Market Report 2026

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Respiratory Endotherapy Devices Market Expected to Reach $4.66 Billion by 2030

    Respiratory Endotherapy Devices Market Expected to Reach $4.66 Billion by 2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Will The Market Size Of The Respiratory Endotherapy Devices Market Evolve From 2026 To 2030?

    The respiratory endotherapy devices market size has experienced significant expansion in recent years. It is anticipated to increase from $3.32 billion in 2025 to $3.54 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. Historically, this growth has been fueled by factors such as a rise in chronic respiratory diseases, improved lung cancer diagnosis, the expansion of interventional pulmonology, growth in hospital endoscopy units, and an elevated demand for minimally invasive procedures.

    The market size for respiratory endotherapy devices is projected to experience robust growth in the upcoming years. It is anticipated to expand to $4.66 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is attributable to several factors, including an increase in early lung screening programs, the adoption of robotic bronchoscopy, a rise in outpatient pulmonary procedures, the integration of advanced imaging, and a growing demand for precision airway therapy. Prominent trends expected in this period involve minimally invasive airway intervention devices, the increasing use of disposable bronchoscopes, image guided bronchoscopic procedures, sophisticated endobronchial ablation systems, and intelligent navigation bronchoscopy tools.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=33296&type=smp

    Which Major Factors Are Driving The Expansion Of The Respiratory Endotherapy Devices Market?

    The increasing integration of robotic-assisted bronchoscopy is anticipated to boost the expansion of the respiratory endotherapy devices market in the future. These systems represent sophisticated technologies facilitating accurate navigation within the airways, thereby enhancing diagnostic precision and treatment results. Growing demand for these systems stems from healthcare professionals’ pursuit of less invasive options that cut down procedure durations, bolster patient safety, and optimize clinical workflows. Respiratory endotherapy devices incorporating robotic aid assist in intricate procedures through the provision of real-time imaging, improved handling, and superior control. For example, data from September 2025 by the European Respiratory Society International Congress, a Switzerland-based membership organization, indicates that the adoption of robotic-assisted bronchoscopy combined with integrated cone beam CT for peripheral lung lesions reached 84.6% in 2025, a significant increase from only 23.1% using conventional bronchoscopy in 2024. Consequently, the expanding use of robotic-assisted bronchoscopy is fueling the expansion of the respiratory endotherapy devices market.

    Which Segment Areas Are Covered In The Respiratory Endotherapy Devices Market Analysis?

    The respiratory endotherapy devices market covered in this report is segmented –

    1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Systems; Biopsy Forceps; Guidewires; Catheters; Airway Stents; Endobronchial Valves; Ablation Devices; Other Endotherapy Accessories

    2) By Diagnostic Devices: Trans Bronchial Aspiration; Biopsy Forceps; Cytology Brushes; Other Diagnostic Devices

    3) By Patient Type: Adult Patients; Pediatric Patients

    4) By Specialist: Hospitals; Diagnostic Centers; Ambulatory Surgical Centers

    5) By End User: Peripheral Vascular Intervention; Endovascular Interventions; Cardiac; Interventional Radiology; Venous; Other End Users

    Subsegments:

    1) By Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Video Bronchoscopes; Disposable Bronchoscopes; Therapeutic Bronchoscopes

    2) By Endobronchial Ultrasound Systems: Radial Endobronchial Ultrasound Systems; Linear Endobronchial Ultrasound Systems; Portable Endobronchial Ultrasound Systems; Cart Based Endobronchial Ultrasound Systems; High Resolution Endobronchial Ultrasound Systems

    3) By Biopsy Forceps: Flexible Biopsy Forceps; Rigid Biopsy Forceps; Disposable Biopsy Forceps; Alligator Jaw Biopsy Forceps; Cup Biopsy Forceps

    4) By Guidewires: Hydrophilic Guidewires; Non Coated Guidewires; Steerable Guidewires; Flexible Tip Guidewires; High Strength Guidewires

    5) By Catheters: Balloon Catheters; Aspiration Catheters; Delivery Catheters; Diagnostic Catheters; Therapeutic Catheters

    6) By Airway Stents: Silicone Airway Stents; Metallic Airway Stents; Covered Airway Stents; Uncovered Airway Stents; Expandable Airway Stents

    7) By Endobronchial Valves: One Way Endobronchial Valves; Permanent Endobronchial Valves; Temporary Endobronchial Valves; Adjustable Endobronchial Valves; Implantable Endobronchial Valves

    8) By Ablation Devices: Radiofrequency Ablation Devices; Cryoablation Devices; Laser Ablation Devices; Thermal Ablation Devices; Microwave Ablation Devices

    9) By Other Endotherapy Accessories: Suction Tubes; Specimen Collection Traps; Bronchoscopy Brushes; Biopsy Needles; Airway Dilators

    What Key Developments And Trends Are Impacting The Respiratory Endotherapy Devices Market?

    Leading companies in the respiratory endotherapy devices market are concentrating on developing advanced solutions, such as endobronchial valves, to minimize treatment risks while achieving targeted lung volume reduction without permanent tissue removal. An endobronchial valve is a minimally invasive implant inserted via bronchoscopy into selected airways to block airflow to diseased lung regions, enabling healthier areas to function more effectively. For example, in February 2024, Olympus Canada Inc., a medical technology firm based in Canada, launched the Spiration Valve System for the treatment of severe emphysema. This umbrella-shaped device is designed to be placed in the most severely diseased lung regions using a minimally invasive bronchoscopic procedure. It uniquely redirects airflow away from hyperinflated lung areas toward healthier tissue, supporting improved respiratory mechanics. As the only endobronchial valve therapy currently accessible in Canada, it addresses an unmet need in the management of severe emphysema. Clinical evidence from the EMPROVE trial demonstrates sustained benefits over 24 months, including significant improvements in lung function, breathlessness, and patient quality of life.

    Which Leading Firms Are Contributing To The Growth Of The Respiratory Endotherapy Devices Market?

    Major companies operating in the respiratory endotherapy devices market are Johnson & Johnson, Medtronic plc, Siemens Healthineers, Stryker Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Intuitive Surgical Inc., Olympus Corporation, Hoya Corporation, Steris Healthcare, Teleflex Incorporated, Karl Storz SE & Co. KG, CookMedical, Merit Medical Systems Inc., Ambu A/S, Vygon, Richard Wolf GmbH, Vapotherm Inc, Scholly Fiberoptic GmbH, Clarus Medical LLC, ENDO-FLEX GmbH, The Lung Docs Inc., and Broncus Medical Inc.

    Read the full respiratory endotherapy devices market report here:

    https://www.thebusinessresearchcompany.com/report/respiratory-endotherapy-devices-market-report

    Which Regions Are Poised For Strategic Growth In The Respiratory Endotherapy Devices Market?

    North America was the largest region in the respiratory endotherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory endotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Respiratory Endotherapy Devices Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=33296&type=smp

    Browse Through More Reports Similar to the Global Respiratory Endotherapy Devices Market 2026, By The Business Research Company

    Respiratory Devices And Equipment Therapeutic Market Report 2026

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

    Endotherapy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/endotherapy-devices-global-market-report

    Respiratory Devices And Equipment Therapeutic And Diagnostic Market Report 2026

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Respiratory Endotherapy Devices Market Expected to Reach $4.66 Billion by 2030

    Respiratory Endotherapy Devices Market Expected to Reach $4.66 Billion by 2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Will The Market Size Of The Respiratory Endotherapy Devices Market Evolve From 2026 To 2030?

    The respiratory endotherapy devices market size has experienced significant expansion in recent years. It is anticipated to increase from $3.32 billion in 2025 to $3.54 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.9%. Historically, this growth has been fueled by factors such as a rise in chronic respiratory diseases, improved lung cancer diagnosis, the expansion of interventional pulmonology, growth in hospital endoscopy units, and an elevated demand for minimally invasive procedures.

    The market size for respiratory endotherapy devices is projected to experience robust growth in the upcoming years. It is anticipated to expand to $4.66 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.1%. This expansion during the forecast period is attributable to several factors, including an increase in early lung screening programs, the adoption of robotic bronchoscopy, a rise in outpatient pulmonary procedures, the integration of advanced imaging, and a growing demand for precision airway therapy. Prominent trends expected in this period involve minimally invasive airway intervention devices, the increasing use of disposable bronchoscopes, image guided bronchoscopic procedures, sophisticated endobronchial ablation systems, and intelligent navigation bronchoscopy tools.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=33296&type=smp

    Which Major Factors Are Driving The Expansion Of The Respiratory Endotherapy Devices Market?

    The increasing integration of robotic-assisted bronchoscopy is anticipated to boost the expansion of the respiratory endotherapy devices market in the future. These systems represent sophisticated technologies facilitating accurate navigation within the airways, thereby enhancing diagnostic precision and treatment results. Growing demand for these systems stems from healthcare professionals’ pursuit of less invasive options that cut down procedure durations, bolster patient safety, and optimize clinical workflows. Respiratory endotherapy devices incorporating robotic aid assist in intricate procedures through the provision of real-time imaging, improved handling, and superior control. For example, data from September 2025 by the European Respiratory Society International Congress, a Switzerland-based membership organization, indicates that the adoption of robotic-assisted bronchoscopy combined with integrated cone beam CT for peripheral lung lesions reached 84.6% in 2025, a significant increase from only 23.1% using conventional bronchoscopy in 2024. Consequently, the expanding use of robotic-assisted bronchoscopy is fueling the expansion of the respiratory endotherapy devices market.

    Which Segment Areas Are Covered In The Respiratory Endotherapy Devices Market Analysis?

    The respiratory endotherapy devices market covered in this report is segmented –

    1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Systems; Biopsy Forceps; Guidewires; Catheters; Airway Stents; Endobronchial Valves; Ablation Devices; Other Endotherapy Accessories

    2) By Diagnostic Devices: Trans Bronchial Aspiration; Biopsy Forceps; Cytology Brushes; Other Diagnostic Devices

    3) By Patient Type: Adult Patients; Pediatric Patients

    4) By Specialist: Hospitals; Diagnostic Centers; Ambulatory Surgical Centers

    5) By End User: Peripheral Vascular Intervention; Endovascular Interventions; Cardiac; Interventional Radiology; Venous; Other End Users

    Subsegments:

    1) By Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Video Bronchoscopes; Disposable Bronchoscopes; Therapeutic Bronchoscopes

    2) By Endobronchial Ultrasound Systems: Radial Endobronchial Ultrasound Systems; Linear Endobronchial Ultrasound Systems; Portable Endobronchial Ultrasound Systems; Cart Based Endobronchial Ultrasound Systems; High Resolution Endobronchial Ultrasound Systems

    3) By Biopsy Forceps: Flexible Biopsy Forceps; Rigid Biopsy Forceps; Disposable Biopsy Forceps; Alligator Jaw Biopsy Forceps; Cup Biopsy Forceps

    4) By Guidewires: Hydrophilic Guidewires; Non Coated Guidewires; Steerable Guidewires; Flexible Tip Guidewires; High Strength Guidewires

    5) By Catheters: Balloon Catheters; Aspiration Catheters; Delivery Catheters; Diagnostic Catheters; Therapeutic Catheters

    6) By Airway Stents: Silicone Airway Stents; Metallic Airway Stents; Covered Airway Stents; Uncovered Airway Stents; Expandable Airway Stents

    7) By Endobronchial Valves: One Way Endobronchial Valves; Permanent Endobronchial Valves; Temporary Endobronchial Valves; Adjustable Endobronchial Valves; Implantable Endobronchial Valves

    8) By Ablation Devices: Radiofrequency Ablation Devices; Cryoablation Devices; Laser Ablation Devices; Thermal Ablation Devices; Microwave Ablation Devices

    9) By Other Endotherapy Accessories: Suction Tubes; Specimen Collection Traps; Bronchoscopy Brushes; Biopsy Needles; Airway Dilators

    What Key Developments And Trends Are Impacting The Respiratory Endotherapy Devices Market?

    Leading companies in the respiratory endotherapy devices market are concentrating on developing advanced solutions, such as endobronchial valves, to minimize treatment risks while achieving targeted lung volume reduction without permanent tissue removal. An endobronchial valve is a minimally invasive implant inserted via bronchoscopy into selected airways to block airflow to diseased lung regions, enabling healthier areas to function more effectively. For example, in February 2024, Olympus Canada Inc., a medical technology firm based in Canada, launched the Spiration Valve System for the treatment of severe emphysema. This umbrella-shaped device is designed to be placed in the most severely diseased lung regions using a minimally invasive bronchoscopic procedure. It uniquely redirects airflow away from hyperinflated lung areas toward healthier tissue, supporting improved respiratory mechanics. As the only endobronchial valve therapy currently accessible in Canada, it addresses an unmet need in the management of severe emphysema. Clinical evidence from the EMPROVE trial demonstrates sustained benefits over 24 months, including significant improvements in lung function, breathlessness, and patient quality of life.

    Which Leading Firms Are Contributing To The Growth Of The Respiratory Endotherapy Devices Market?

    Major companies operating in the respiratory endotherapy devices market are Johnson & Johnson, Medtronic plc, Siemens Healthineers, Stryker Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Intuitive Surgical Inc., Olympus Corporation, Hoya Corporation, Steris Healthcare, Teleflex Incorporated, Karl Storz SE & Co. KG, CookMedical, Merit Medical Systems Inc., Ambu A/S, Vygon, Richard Wolf GmbH, Vapotherm Inc, Scholly Fiberoptic GmbH, Clarus Medical LLC, ENDO-FLEX GmbH, The Lung Docs Inc., and Broncus Medical Inc.

    Read the full respiratory endotherapy devices market report here:

    https://www.thebusinessresearchcompany.com/report/respiratory-endotherapy-devices-market-report

    Which Regions Are Poised For Strategic Growth In The Respiratory Endotherapy Devices Market?

    North America was the largest region in the respiratory endotherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory endotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Respiratory Endotherapy Devices Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=33296&type=smp

    Browse Through More Reports Similar to the Global Respiratory Endotherapy Devices Market 2026, By The Business Research Company

    Respiratory Devices And Equipment Therapeutic Market Report 2026

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

    Endotherapy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/endotherapy-devices-global-market-report

    Respiratory Devices And Equipment Therapeutic And Diagnostic Market Report 2026

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Respiratory Endotherapy Devices Market Performance Outlook 2026–2030: Revenue to Hit $4.66 Billion at 7.1% CAGR

    Respiratory Endotherapy Devices Market Performance Outlook 2026–2030: Revenue to Hit $4.66 Billion at 7.1% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the respiratory endotherapy devices market from 2026–2035 with trusted insights from The Business Research Company

    What is the expected shift in the Respiratory Endotherapy Devices Market’s size between 2026 and 2030?

    The respiratory endotherapy devices market size has shown significant growth in recent years. It is anticipated to increase from $3.32 billion in 2025 to $3.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. The expansion observed historically can be attributed to the rise in chronic respiratory diseases, growth in lung cancer diagnosis, expansion of interventional pulmonology, hospital endoscopy unit growth, and the demand for minimally invasive procedures.

    The respiratory endotherapy devices market size is poised for substantial expansion over the coming years, with projections indicating a rise to $4.66 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.1%. This anticipated growth is driven by several factors, including the increase in early lung screening programs, the adoption of robotic bronchoscopy, the expansion of outpatient pulmonary procedures, the integration of advanced imaging, and the demand for precision airway therapy. Prominent trends throughout the forecast period are expected to encompass minimally invasive airway intervention devices, the widespread use of disposable bronchoscopes, image-guided bronchoscopic procedures, advanced endobronchial ablation systems, and intelligent navigation bronchoscopy tools.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=33296&type=smp

    Which Drivers Are Shaping Strategic Decisions In The Respiratory Endotherapy Devices Market?

    The increasing integration of robotic-assisted bronchoscopy is expected to drive the growth of the respiratory endotherapy devices market in the coming years. Robotic-assisted bronchoscopy systems represent advanced technology, enabling precise navigation within the respiratory tract and thereby improving diagnostic accuracy and therapeutic outcomes. The demand for these systems is growing as healthcare providers increasingly seek minimally invasive solutions that effectively reduce procedure time, enhance patient safety, and improve overall clinical efficiency. Respiratory endotherapy devices with robotic assistance are crucial for supporting complex interventions by offering real-time imaging capabilities, superior maneuverability, and enhanced control. For instance, in September 2025, as per insights from the European Respiratory Society International Congress, a Switzerland-based membership organization, the utilization of robotic-assisted bronchoscopy coupled with integrated cone beam CT for peripheral lung lesions saw a rise to 84.6% in 2025, significantly up from just 23.1% when using conventional bronchoscopy in 2024. This rising adoption of robotic-assisted bronchoscopy is thus propelling the expansion of the respiratory endotherapy devices market.

    What Segment Classifications Make Up The Respiratory Endotherapy Devices Market?

    The respiratory endotherapy devices market covered in this report is segmented –

    1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Systems; Biopsy Forceps; Guidewires; Catheters; Airway Stents; Endobronchial Valves; Ablation Devices; Other Endotherapy Accessories

    2) By Diagnostic Devices: Trans Bronchial Aspiration; Biopsy Forceps; Cytology Brushes; Other Diagnostic Devices

    3) By Patient Type: Adult Patients; Pediatric Patients

    4) By Specialist: Hospitals; Diagnostic Centers; Ambulatory Surgical Centers

    5) By End User: Peripheral Vascular Intervention; Endovascular Interventions; Cardiac; Interventional Radiology; Venous; Other End Users

    Subsegments:

    1) By Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Video Bronchoscopes; Disposable Bronchoscopes; Therapeutic Bronchoscopes

    2) By Endobronchial Ultrasound Systems: Radial Endobronchial Ultrasound Systems; Linear Endobronchial Ultrasound Systems; Portable Endobronchial Ultrasound Systems; Cart Based Endobronchial Ultrasound Systems; High Resolution Endobronchial Ultrasound Systems

    3) By Biopsy Forceps: Flexible Biopsy Forceps; Rigid Biopsy Forceps; Disposable Biopsy Forceps; Alligator Jaw Biopsy Forceps; Cup Biopsy Forceps

    4) By Guidewires: Hydrophilic Guidewires; Non Coated Guidewires; Steerable Guidewires; Flexible Tip Guidewires; High Strength Guidewires

    5) By Catheters: Balloon Catheters; Aspiration Catheters; Delivery Catheters; Diagnostic Catheters; Therapeutic Catheters

    6) By Airway Stents: Silicone Airway Stents; Metallic Airway Stents; Covered Airway Stents; Uncovered Airway Stents; Expandable Airway Stents

    7) By Endobronchial Valves: One Way Endobronchial Valves; Permanent Endobronchial Valves; Temporary Endobronchial Valves; Adjustable Endobronchial Valves; Implantable Endobronchial Valves

    8) By Ablation Devices: Radiofrequency Ablation Devices; Cryoablation Devices; Laser Ablation Devices; Thermal Ablation Devices; Microwave Ablation Devices

    9) By Other Endotherapy Accessories: Suction Tubes; Specimen Collection Traps; Bronchoscopy Brushes; Biopsy Needles; Airway Dilators

    Which Trends Are Shaping Activity Within The Respiratory Endotherapy Devices Market?

    Leading companies in the respiratory endotherapy devices market are focusing on developing advanced solutions, such as endobronchial valves, to minimize treatment risks while achieving targeted lung volume reduction without permanent tissue removal. An endobronchial valve is a minimally invasive implant inserted via bronchoscopy into specific airways to block airflow to diseased lung regions, allowing healthier areas to function more effectively. For instance, in February 2024, Olympus Canada Inc., a Canada-based medical technology company, launched the Spiration Valve System for the treatment of severe emphysema. It is an umbrella-shaped device designed for placement in the most severely diseased lung regions using a minimally invasive bronchoscopic procedure. It uniquely redirects airflow away from hyperinflated lung areas toward healthier tissue, supporting improved respiratory mechanics. As the only endobronchial valve therapy currently available in Canada, it addresses an unmet need in severe emphysema management. Clinical evidence from the EMPROVE trial demonstrates durable benefits through 24 months, including meaningful improvements in lung function, breathlessness, and patient quality of life.

    Which Key Market Players Are Investing In Expansion And Innovation Within The Respiratory Endotherapy Devices Market?

    Major companies operating in the respiratory endotherapy devices market are Johnson & Johnson, Medtronic plc, Siemens Healthineers, Stryker Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Intuitive Surgical Inc., Olympus Corporation, Hoya Corporation, Steris Healthcare, Teleflex Incorporated, Karl Storz SE & Co. KG, CookMedical, Merit Medical Systems Inc., Ambu A/S, Vygon, Richard Wolf GmbH, Vapotherm Inc, Scholly Fiberoptic GmbH, Clarus Medical LLC, ENDO-FLEX GmbH, The Lung Docs Inc., and Broncus Medical Inc.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/respiratory-endotherapy-devices-market-report

    Which Regions Are Poised For Strategic Growth In The Respiratory Endotherapy Devices Market?

    North America was the largest region in the respiratory endotherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the respiratory endotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Respiratory Endotherapy Devices Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=33296&type=smp

    Browse Through More Reports Similar to the Global Respiratory Endotherapy Devices Market 2026, By The Business Research Company

    Respiratory Devices And Equipment Therapeutic Market Report 2026

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-global-market-report

    Endotherapy Devices Market Report 2026

    https://www.thebusinessresearchcompany.com/report/endotherapy-devices-global-market-report

    Respiratory Devices And Equipment Therapeutic And Diagnostic Market Report 2026

    https://www.thebusinessresearchcompany.com/report/respiratory-devices-and-equipment-therapeutic-and-diagnostic-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model